BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27365893)

  • 1. Bevacizumab-induced pityriasis rubra pilaris-like eruption.
    Brown S; Fletcher JW; Fiala KH
    Proc (Bayl Univ Med Cent); 2016 Jul; 29(3):335-6. PubMed ID: 27365893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatomyositis with a pityriasis rubra pilaris-like eruption: an uncommon cutaneous manifestation in dermatomyositis.
    Polat M; Lenk N; Ustün H; Oztaş P; Artüz F; Alli N
    Pediatr Dermatol; 2007; 24(2):151-4. PubMed ID: 17461814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.
    Di Stefani A; Galluzzo M; Talamonti M; Chiricozzi A; Costanzo A; Chimenti S
    J Dermatol Case Rep; 2013 Mar; 7(1):5-9. PubMed ID: 23580907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab.
    Hanfstingl K; Pekar-Lukacs A; Motz R; Guenova E; Hoetzenecker W
    Case Rep Dermatol; 2018; 10(2):97-100. PubMed ID: 29867429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris.
    Boyd AH; Polcari IC
    Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatomyositis with a pityriasis rubra pilaris-like eruption: a little-known distinctive cutaneous manifestation of dermatomyositis.
    Requena L; Grilli R; Soriano L; Escalonilla P; Fariña C; Martín L
    Br J Dermatol; 1997 May; 136(5):768-71. PubMed ID: 9205515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pityriasis rubra pilaris partially responsive to treatment with upadacitinib: A case report.
    Saad M; Spurr A; Lipson J
    SAGE Open Med Case Rep; 2023; 11():2050313X231160927. PubMed ID: 37009550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab for the treatment of pityriasis rubra pilaris: a case report.
    Wassef C; Lombardi A; Rao BK
    Cutis; 2012 Nov; 90(5):244-7. PubMed ID: 23270195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pityriasis rubra pilaris: a review of diagnosis and treatment.
    Cohen PR; Prystowsky JH
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):801-7. PubMed ID: 2654219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pityriasis rubra pilaris as a systemic disease.
    Kamarachev J; Grozdev I; Darlenski R; Tsankov N
    Clin Dermatol; 2019; 37(6):657-662. PubMed ID: 31864444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular Psoriasis: Differentiation from Pityriasis Rubra Pilaris-An Illustrative Case and Review of the Literature.
    Nguyen CV; Farah RS; Maguiness SM; Miller DD
    Pediatr Dermatol; 2017 Jan; 34(1):e65-e68. PubMed ID: 27874201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pityriasis rubra pilaris-like eruption following insulin therapy initiation.
    Badri T; Zaouak A; Lakhoua G; Koubaa W; Fennich S; Zaiem A
    Dermatol Pract Concept; 2016 Oct; 6(4):19-21. PubMed ID: 27867741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial pityriasis rubra pilaris.
    Vanderhooft SL; Francis JS; Holbrook KA; Dale BA; Fleckman P
    Arch Dermatol; 1995 Apr; 131(4):448-53. PubMed ID: 7726588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's Varicelliform Eruption After Treatment With Ixekizumab in a Patient With Pityriasis Rubra Pilaris.
    Guenther JS; Ahronowitz I; Worswick S
    Cureus; 2023 May; 15(5):e38395. PubMed ID: 37265883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Rare Post-infectious Rash: Pityriasis Rubra Pilaris After COVID-19 Infection.
    Duncan P; Flood D; Dietz C
    Cureus; 2023 Aug; 15(8):e43810. PubMed ID: 37731438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin.
    Mota F; Carvalho S; Sanches M; Selores M
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):15-7. PubMed ID: 27014774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pityriasis rubra pilaris: an unusual cutaneous complication of AIDS.
    Bonomo RA; Korman N; Nagashima-Whalen L; Briggs J; Graham R; Salata RA
    Am J Med Sci; 1997 Aug; 314(2):118-21. PubMed ID: 9258214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic Pityriasis Rubra Pilaris Preceding Leukemia.
    Vance P; Wyles S; Alavi A
    Adv Skin Wound Care; 2022 Jun; 35(6):1-4. PubMed ID: 35703855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical Juvenile Pityriasis Rubra Pilaris: A Case Report of Early Onset With Late Diagnosis.
    Albrakati BA; Alshareef IA; Alhawsawi WK; Al Hawsawi KA
    Cureus; 2022 Oct; 14(10):e30234. PubMed ID: 36381776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of refractory pityriasis rubra pilaris: challenges and solutions.
    Moretta G; De Luca EV; Di Stefani A
    Clin Cosmet Investig Dermatol; 2017; 10():451-457. PubMed ID: 29184428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.